Mimvey
Tablet, film coated · Oral · Prescription
Boxed warning
Estrogen Plus Progestin Therapy
Cardiovascular Disorders and Probable Dementia
The Women’s Health Initiative (WHI) estrogen plus progestin substudy reported increased risks of deep vein thrombosis (DVT), pulmonary embolism (PE), stroke and myocardial infarction (MI) in postmenopausal women (50 to 79 years of age) during 5.6 years of treatment with daily oral conjugated estrogen (CE) [0.625 mg] combined with medroxyprogesterone acetate (MPA) [2.5 mg], relative to placebo [see Warnings and Precautions (5.1), and Clinical Studies (14.5)].
…
Uses
Mimvey is indicated for:
1.1 Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause
1.2 Treatment of Moderate to Severe Symptoms of Vulvar and Vaginal Atrophy due to Menopause
Limitation of Use
When prescribing solely for the treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause, first consider the use of topical vaginal products.
1.3 Prevention of Postmenopausal Osteoporosis
When prescribing solely for the prevention of postmenopausal osteoporosis, first consider the use of non-estrogen medications. Consider estrogen therapy only for women at significant risk of osteoporosis.
From the FDA label of Teva Pharmaceuticals Usa Inc, version of May 31, 2024. Not medical advice: ask your doctor or pharmacist.
Active ingredients
- Estradiol
- Norethindrone acetate
Generic name
- Estradiol and Norethindrone Acetate
Drug class
- Estrogen
- Estrogen Receptor Agonists
- Progestin
What it looks like
| Imprint | Look | Manufacturer |
|---|---|---|
| b 34 | White, Round, 6 mm | Teva Pharmaceuticals Usa Inc |
Inactive ingredients and allergens
- Lactose: listed
- Teva Pharmaceuticals Usa Inc, 1 mg/1, .5 mg/1: silicon dioxide, copovidone k25-31, starch, corn, hypromellose 2910 (3 mpa.s), hypromellose 2910 (6 mpa.s), lactose monohydrate, magnesium stearate, polyethylene glycol 400, polysorbate 80, titanium dioxide
From each product's FDA label; they differ between manufacturers and strengths. The app shows every product and finds those without an allergen.
FDA recalls
- Class III · Terminated · Jan 7, 2022 · Teva Pharmaceuticals USA
Mislabeling - Class III · Terminated · Jan 7, 2022 · Teva Pharmaceuticals USA
Mislabeling
A recall covers the products and lots it names, not every package. From FDA Enforcement Reports; the app alerts you to new ones for your drugs.
Brand and generics
- Abigale Tablet
- Abigale lo Tablet
- Activella Tablet, film coated
- Estradiol / Norethindrone Acetate Tablet, film coated
- Estradiol and Norethindrone Acetate Tablet
- Etyqa Tablet, film coated
- Lopreeza Tablet, film coated
Same ingredient and dosage form in the FDA Orange Book; ask a pharmacist before switching.
Official FDA label
- Teva Pharmaceuticals Usa Inc on DailyMed, version of May 31, 2024
Read the full label as text, with its contents and search, in the app.
Data: FDA NDC Directory, DailyMed labels, Orange Book, Purple Book and Enforcement Reports, updated Nov 17, 2026.